In 2008 the Tashkent Scientific Research Institute for Vaccines and Serums of Uzpharmsanoat state joint-stock concern will deliver medicine worth US$14 million to Armenia and Georgia, Uzbekistan Today reported.
"It is one of the first agreements on exporting the Uzbek vaccines to foreign consumers", commented Boltaboy Kaharov, Director of the Tashkent Scientific Research Institute for Vaccines and Serums. "At present we are having talks with the Afghan partners to deliver medicine to this country".
The unique institute in Central Asia to produce vaccines and serums and develop new medications is manufacturing medicine of two types now: staphylococcus vaccine and "Norma flora" (bifid bacterium and lactose bacterium). In near time the institute will launch production of up to thirty types of medicine demanded in the home as well as foreign markets.
"At present the vaccine output is growing in Uzbekistan, and specialists predict great number of customers", noted B. Kaharov. However, the institute will be busy with conducting research because medicine production is additional activity for it. We intend to cooperate actively with such young companies of the Uzbek pharmaceutical industry as Biopharm and Noopharm having good conditions for vaccine production.""We will develop cooperation with our foreign partners. We have already reached agreement with the authorities of Microgene scientific industrial enterprise of the Russian Federation to set a line of packing hydrophobia vaccines in our institute. We plan to launch its production in Uzbekistan," he said.